Advances in Motion provides health care professionals with information about the latest breakthroughs, research and clinical advances from Massachusetts General Hospital.
EXPLORE OUR SPECIALTIES BROWSE OUR TOPICS SUBSCRIBE TO RECEIVE UPDATES
Featured In Urology
New Research Supports Trimodality Therapy for Bladder Cancer
A new Massachusetts General Hospital study compares bladder cancer treatment options and strongly supports bladder preservation with trimodality therapy.
Featured In Cardiovascular
Update in Clinical Cardiology Course: Q&A With Dr. Rory Weiner
In this Q&A, Rory Weiner, MD, discusses what is new in this year's Update in Clinical Cardiology 2023 course and what makes this course such a unique learning experience.
Featured In Radiology
Innovative Therapy for Low Back Pain Takes the Fight Directly to the Source
An emerging technique, radiofrequency ablation of the basivertebral nerve, offers new hope to patients who experience a specific type of chronic low back pain.
Featured In Geriatrics and Palliative Care
New Multidisciplinary Clinic Aims to Improve Surgical Outcomes in Older Adults
A multidisciplinary team at Massachusetts General Hospital offers specialized geriatric assessments and personalized interventions to optimize surgical outcomes in older adults.
Featured In Otolaryngology
New Biomarker for Cochlear Nerve Degeneration Proposed
Stéphane F. Maison, AuD, PhD, and colleagues used high-pass filtering to isolate a neural spiking component during electrocochleography that correlates with performance on difficult word recognition tasks, used as a proxy for cochlear nerve degeneration.
The Latest Neuroscience Advances
Level of Engagement With Smartphone-delivered Psychotherapy Not Linked to Treatment Response
Hilary Weingarden, PhD, Sabine Willhelm, PhD, and colleagues have determined individuals with body dysmorphic disorder who spend more total time or sessions on smartphone-delivered cognitive–behavioral therapy don't necessarily improve more than those who were lighter users.
Co-transplantation of Regulatory T Cells Improves Cell Replacement Therapy for Parkinson's Disease
Research at Massachusetts General Hospital suggests a novel strategy for enhancing the efficacy and safety of cell replacement therapy in the nervous system: co-transplantation of dopamine progenitor cells with regulatory T cells to modulate the host immune response triggered by needle trauma.
Advances Specialties
Digestive Health
Proof of Concept: Gut Microbiota Dysbiosis May Influence Postoperative Delirium
Yiying Zhang, MD, PhD, Zhongcong Xie, MD, PhD, and colleagues have provided proof of concept in patients that the gut–brain axis contributes to postoperative delirium, and they identified postoperative Parabacteroides distasonis as being associated with the delirium.
Endocrinology
Pathways Case Record: POEMS Disease
The Pathways Service investigated a 65-year-old woman admitted with recurrent fluid buildup in the abdomen and a history of IgA lambda gammopathy, neuropathy, leg swelling, hypothyroidism, and more. She was diagnosed with POEMS (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal protein, Skin changes) syndrome.
Oncology
Researching Radiation Therapy for Transgender Cancer Patients
A Mass General Cancer Center radiation oncologist published a unique review of considerations in radiation for patients with cancer who have had gender-affirming surgery.
September 30, 2023 - October 4, 2023
Conference: AAO-HNSF 2023 Annual Meeting
Mass Eye and Ear researchers will present their latest work at the American Academy of Otolaryngology—Head and Neck Surgery and Foundation (AAO-HNSF) 2023 Annual Meeting. This premier event for otolaryngology takes place September 30–October 4 in Nashville, TN.
October 1-4, 2023
Conference: ASTRO 2023 Annual Meeting
Leaders from the Mass General Cancer Center will join international colleagues at this year's American Society for Radiation Oncology Annual Meeting, held October 1-4, 2023, in San Diego.
Brain mechanisms of vagus nerve stimulation and stress reduction training for migraine
The study involves multiple visits over 6 months. You will complete an 8-week stress reduction treatment that includes a medical device worn in the ear and attend MRI and PET scans. You will also complete daily migraine diaries online.
PILOT STUDY EVALUATING THE IMPACT OF STRESS REDUCTION ON ATHEROSCLEROTIC INFLAMMATION
We are seeking individuals who self-identify as having high stress to participate in a randomized study using a mindfulness-based, stress-reduction intervention and PET-MR imaging.